Respiratory syncytial virus- and human metapneumovirus-associated emergency department and hospital burden in adults

Kyle Widmer, Marie R Griffin, Yuwei Zhu, John V Williams, H Keipp Talbot, Kyle Widmer, Marie R Griffin, Yuwei Zhu, John V Williams, H Keipp Talbot

Abstract

Objective: Determine the burden of illness associated with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) in adults, especially young adults.

Design: Prospective surveillance study using RT-PCR for the diagnosis of RSV and HMPV.

Setting: One academic Emergency Department (ED), one academic hospital and three middle Tennessee community hospitals.

Sample: We prospectively enrolled Middle Tennessee residents ≥18 years old evaluated in the emergency department (ED) or hospitalized for respiratory symptoms May 2009 through April 2010. We collected nose/throat specimens for RSV and HMPV reverse-transcriptase polymerase chain reaction (RT-PCR) testing and obtained demographic and clinical data.

Main outcome measures: Rates of ED visits and hospitalizations were calculated using the proportion of enrolled patients positive for each virus multiplied by the number of Middle Tennessee residents evaluated in EDs and/or hospitalized in Tennessee for acute respiratory illness during the study period.

Results: Three thousand two hundred and fifty six patients were eligible; 1477 (45·4%) were enrolled; 1248 (84·5%) of these consented to additional testing and had adequate samples. RT-PCR identified 32 (2·6%) patients with RSV and 33 (2·6%) with HMPV. The median duration of symptoms before ED presentation was 3·3 days with RSV and 2·8 days with HMPV, and before hospital admission was 4·5 days with RSV and 3·5 days with HMPV. The annual hospitalization and ED visit rates were similar for RSV and HMPV. The hospitalization rate associated with each virus was about 10 per 10 000 persons aged ≥50 years; ED rates were approximately 2 times higher. Hospitalization rates were about 2 per 10 000 persons aged 18-49 years, with ED rates 5-6 times higher.

Conclusion: RSV and MPV are associated with substantial disease in adults, with hospitalization and ED visits rates increasing with age.

Keywords: Burden of illness; hospitalizations; human metapneumovirus; older adults; respiratory syncytial virus.

© 2014 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

Figures

Figure 1
Figure 1
Eligibility and enrollment: 3256 were approached for enrollment, 1477 agreed to testing of specimens for influenza alone, and of those, 1262 agreed to further testing for other viruses; 1248 had adequate samples to test for RSV and HMPV.
Figure 2
Figure 2
Number of adults enrolled with ARI-associated ED visit or hospitalization with RSV or HMPV identified by month, May 2009 through April 2010.

References

    1. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012;206:56–62.
    1. Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis. 2011;203:500–508.
    1. Kodani M, Yang G, Conklin LM, et al. Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol. 2011;49:2175–2182.
    1. Klemenc J, Asad Ali S, Johnson M, et al. Real-time reverse transcriptase PCR assay for improved detection of human metapneumovirus. J Clin Virol. 2012;54:371–375.
    1. Maertzdorf J, Wang CK, Brown JB, et al. Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol. 2004;42:981–986.
    1. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol. 1980;112:798–811.
    1. Jansen AGSC, Sanders EAM, Nichol KL, van Loon AM, Hoes AW, Hak E. Decline in influenza-associated mortality among Dutch elderly following the introduction of a nationwide vaccination program. Vaccine. 2008;26:5567–5574.
    1. Jules A, Grijalva CG, Zhu Y, et al. Estimating age-specific influenza-related hospitalization rates during the pandemic (H1N1) 2009 in Davidson Co, TN. Influenza Other Respir Viruses. 2012;6:e63–e71.
    1. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis. 2000;181:831–837.
    1. Talbot HK, Poehling KA, Williams JV, et al. Influenza in older adults: impact of vaccination of school children. Vaccine. 2009;27:1923–1927.
    1. Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis. 2012;54:1427–1436.
    1. Mullooly JP, Bridges CB, Thompson WW, et al. Influenza- and RSV-associated hospitalizations among adults. Vaccine. 2007;25:846–855.
    1. Talbot HK, Falsey AR. The diagnosis of viral respiratory disease in older adults. Clin Infect Dis. 2010;50:747–751.
    1. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352:1749–1759.
    1. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:719–724.
    1. Falsey AR. Human metapneumovirus infection in adults. Pediatr Infect Dis J. 2008;27(10 Suppl):S80–S83.
    1. Self WH, Grijalva CG, Zhu Y, et al. Emergency department visits for influenza A(H1N1)pdm09, Davidson County, Tennessee, USA. Emerg Infect Dis. 2012;18:863–865.
    1. Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc. 2002;50:1498–1503.
    1. Talbot HK, Williams JV, Zhu Y, Poehling KA, Griffin MR, Edwards KM. Failure of routine diagnostic methods to detect influenza in hospitalized older adults. Infect Control Hosp Epidemiol. 2010;31:683–688.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren